OTCMKTS:BIOGY BioGaia AB (publ) (BIOGY) Stock Price, News & Analysis → Man who Predicted Trump 2016 Win: “Prepare for Election Meltdown” (From Paradigm Press) (Ad) Free BIOGY Stock Alerts $12.08 0.00 (0.00%) (As of 06/14/2024 ET) Add Compare Share Share Today's Range$12.08▼$12.0850-Day Range$9.72▼$12.0952-Week Range$8.75▼$12.09VolumeN/AAverage Volume1,110 shsMarket CapitalizationN/AP/E Ratio2.88Dividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartDividendFinancialsSEC FilingsStock AnalysisChartDividendFinancialsSEC Filings Get BioGaia AB (publ) alerts: Email Address Ad Porter & CompanyThe attacks will come for me after releasing this…America’s “Internal Enemies” Exposed New documentary exposes a hidden election plan in Washington D.C. that, if successful, could be more financially and culturally devastating than the dot-com blowup of 2000, the 2008 financial crisis, or the COVID crash.Click here to see how you can protect yourself today. About BioGaia AB (publ) Stock (OTCMKTS:BIOGY)BioGaia AB (publ), a healthcare company, provides probiotic products worldwide. The company operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula. The Adult Health segment provides gut health tablets and oral health lozenges products, as well as cultures, which are used as an ingredient in a licensee's dairy product. The Other segment provides packaging solutions. It sells its products through distribution partners or through its own distribution channels. BioGaia AB (publ) was founded in 1990 and is based in Stockholm, Sweden.Read More BIOGY Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BIOGY Stock News HeadlinesMay 28, 2024 | finance.yahoo.comThree Swedish Dividend Stocks Offering Yields From 4% To 5.9%May 14, 2024 | finance.yahoo.comThree Swedish Dividend Stocks Offering Up To 5.7% YieldSeptember 21, 2023 | uk.investing.comBioGaia AB ser. B (0GTN)September 13, 2023 | wsj.comBioGaia AB Series BAugust 1, 2022 | apnews.comChanged Number of Shares and Votes in IRLAB Therapeutics ABSee More Headlines Receive BIOGY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BioGaia AB (publ) and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Ex-Dividend for 5/30 Dividend5/09/2024Dividend Payable5/30/2024Today6/15/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolOTCMKTS:BIOGY CUSIPN/A CIK1572957 Webwww.biogaia.com Phone(685) 552-9300FaxN/AEmployees210Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio2.88 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleGrowth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.Get This Free Report Key ExecutivesMr. Peter Rothschild M.Sc. Econ. (Age 74)MBA, Founder & Chairman Comp: $1.3MMr. Alexander Kotsinas M.Sc. (Eng.). (Age 57)Executive VP & CFO Comp: $2.98MMs. Theresa P. Agnew (Age 58)CEO & President Ludvig Milesson (Age 47)Chief Operating Officer Mr. Gianfranco Grompone (Age 49)Chief Scientific Officer and VP of Research & Development Ms. Caroline Mofors (Age 52)Chief Legal Officer Ms. Linda Hagglund (Age 51)Vice President of Marketing Ms. Angelika Kjelldorff (Age 55)Chief HR Officer Sebastian Heimfors (Age 50)VP & Chief Commercial Officer Jonathan GromarkSustainability ManagerMore ExecutivesKey Competitors1933 IndustriesOTCMKTS:TGIFF4Cable TV InternationalOTCMKTS:CATV4Front VenturesOTCMKTS:FFNTFAB ScienceOTCMKTS:ABSCFAbacus Health ProductsOTCMKTS:ABAHFView All Competitors BIOGY Stock Analysis - Frequently Asked Questions How have BIOGY shares performed in 2024? BioGaia AB (publ)'s stock was trading at $9.80 at the beginning of 2024. Since then, BIOGY shares have increased by 23.3% and is now trading at $12.08. View the best growth stocks for 2024 here. How often does BioGaia AB (publ) pay dividends? What is the dividend yield for BioGaia AB (publ)? BioGaia AB (publ) announced a dividend on Tuesday, April 30th. Shareholders of record on Friday, May 10th will be paid a dividend of $0.6344 per share on Thursday, May 30th. The ex-dividend date is Thursday, May 9th. This is an increase from the stock's previous dividend of $0.20. Read our dividend analysis for BIOGY. When did BioGaia AB (publ)'s stock split? BioGaia AB (publ)'s stock split before market open on Thursday, May 26th 2022. The 2.5-1 split was announced on Thursday, May 26th 2022. The newly issued shares were issued to shareholders after the market closes on Thursday, May 26th 2022. An investor that had 100 shares of stock prior to the split would have 250 shares after the split. How do I buy shares of BioGaia AB (publ)? Shares of BIOGY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:BIOGY) was last updated on 6/15/2024 by MarketBeat.com Staff From Our PartnersGold Set to EXPLODE!The perfect storm is brewing to drive gold's price through the roof! And our weakening dollars are causing ...Gold Safe Exchange | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredExposed: 3 CENT Crypto to Explode June 24th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredCollect 10%+ Dividends from AI's Explosive Growth?What if I told you there was a way to collect double-digit income from the AI revolution... Without having ...The Oxford Club | SponsoredTiny, One-Half Inch Pellet the Key to INFINITE Energy?It’s a tiny, $1 billion company that holds the key to this power. And yet, it’s the largest company of its ...Eagle Publishing | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioGaia AB (publ) Please log in to your account or sign up in order to add this asset to your watchlist. Share BioGaia AB (publ) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.